HPV vaccination among a community sample of young adult women

Vaccine

Volumn 29, Issue 32, 2011, Pages 5238-5244

  Manhart, Lisa E ^a   Burgess Hull, Albert J ^a   Fleming, Charles B ^a   Bailey, Jennifer A ^a   Haggerty, Kevin P ^a   Catalano, Richard F ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Health Belief Model; HPV; Vaccination; Vaccine acceptability

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CIGARETTE SMOKING; COMMUNITY CARE; DRUG ABUSE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; UNITED STATES; VACCINATION;

ADOLESCENT; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTERVIEWS AS TOPIC; LONGITUDINAL STUDIES; MALE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; SMOKING; UNITED STATES; VACCINATION; WASHINGTON; YOUNG ADULT;

EID: 79960316678     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.05.024     Document Type: Article

References (33)

1. National Cancer Institute. SEER Cancer Statistics Review 1975-2007. 2010 [cited 2010 October 22]; Annual Death Rates for Cervix Uteri Cancer. Available from: http://seer.cancer.gov/csr/1975_2007/browse_csr.php%3Fsection=5%26page=sect_05_table.05.html.
2. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007, 356(19):1915-1927. The FUTURE II Study Group.
3. Romanowski B., de Borba P.C., Naud P.S., Roteli-Martins C.M., De Carvalho N.S., Teixeira J.C., et al. Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6.4 years. Lancet 2009, 374(9706):1975-1985.
4. Center for Disease Control and Prevention FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010, 59(20):626-629.
5. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56(RR-2):1-24.
6. Center for Disease Control and Prevention National, state, and local area vaccination coverage among adolescents aged 13-17 years-United States, 2009. MMWR Morb Mortal Wkly Rep 2010, 59(32):1018-1023.
7. Chao C., Velicer C., Slezak J.M., Jacobsen S.J. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol 2010, 171(3):357-367.
8. Caskey R., Lindau S.T., Alexander G.C. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health 2009, 45(5):453-462.
9. Conroy K., Rosenthal S.L., Zimet G.D., Jin Y., Bernstein D.I., Glynn S., Kahn J.A. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health (Larchmt) 2009, 18(10):1679-1686.
10. Cook R.L., Zhang J., Mullins J., Kauf T., Brumback B., Steingraber H., et al. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in medicaid. J Adolesc Health 2010, 47(6):596-599.
11. Daley E.M., Vamos C.A., Buhi E.R., Kolar S.K., McDermott R.J., Hernandez N., et al. Influences on human papillomavirus vaccination status among female college students. J Womens Health (Larchmt) 2010, 19(10):1885-1891.
12. Licht A.S., Murphy J.M., Hyland A.J., Fix B.V., Hawk L.W., Mahoney M.C. Is use of the human papillomavirus vaccine among female college students related to human papillomavirus knowledge and risk perception?. Sex Transm Infect 2010, 86(1):74-78.
13. Zimet G.D. Improving adolescent health: focus on HPV vaccine acceptance. J Adolesc Health 2005, 37(6 Suppl):S17-S23.
14. Allen J.D., Mohllajee A.P., Shelton R.C., Othus M.K., Fontenot H.B., Hanna R. Stage of adoption of the human papillomavirus vaccine among college women. Prev Med 2009, 48(5):420-425.
15. Cates J.R., Sonenstein F.L. Racial differences in HPV knowledge, HPV vaccine acceptability, and related beliefs among rural, southern women. J Rural Health 2009, 25(1):93-97.
16. Christian W.J., Christian A., Hopenhayn C. Acceptance of the HPV vaccine for adolescent girls: analysis of state-added questions from the BRFSS. J Adolesc Health 2009, 44(5):437-445.
17. Kahn J.A., Rosenthal S.L., Jin Y., Huang B., Namakydoust A., Zimet G.D. Rates of human papillomavirus vaccination, attitudes about vaccination, and human papillomavirus prevalence in young women. Obstet Gynecol 2008, 111(5):1103-1110.
18. Staras S.A., Vadaparampil S.T., Haderxhanaj L.T., Shenkman E.A. Disparities in human papillomavirus vaccine series initiation among adolescent girls enrolled in Florida Medicaid programs, 2006-2008. J Adolesc Health 2010, 47(4):381-388.
19. Zimet G.D., Weiss T.W., Rosenthal S.L., Good M.B., Vichnin M.D. Reasons for non-vaccination against HPV and future vaccination intentions among 19-26 year-old women. BMC Womens Health 2010, 10:27.
20. Chao C., Velicer C., Slezak J.M., Jacobsen S.J. Correlates for completion of 3-dose regimen of HPV vaccine in female members of a managed care organization. Mayo Clin Proc 2009, 84(10):864-870.
21. Dempsey A., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine 2010, 28(4):989-995.
22. Neubrand T.P., Breitkopf C.R., Ruppp R., Breitkopf D., Rosenthal S.L. Factors associated with completion of the human papillomavirus vaccine series. Clin Pediatr (Phila) 2009, 48(9):966-969.
23. Rosenstock I.M. Why people use health services. Milbank Mem Fund Q 1966, 44(3):94-127.
24. Brown E.C., Catalano R.F., Fleming C.B., Haggerty K.P., Abbott R.D. Adolescent substance use outcomes in the Raising Healthy Children project: a two-part latent growth curve analysis. J Consult Clin Psychol 2005, 73(4):699-710.
25. Haggerty K.P., Fleming C.B., Catalano R.F., Harachi T.W., Abbott R.D. Raising healthy children: examining the impact of promoting healthy driving behavior within a social development intervention. Prev Sci 2006, 7(3):257-267.
26. McMorris B.J., Petrie R.S., Catalano R.F., Fleming C.B., Haggerty K.P., Abbott R.D. Use of web and in-person survey modes to gather data from young adults on sex and drug use: an evaluation of cost, time, and survey error based on a randomized mixed-mode design. Eval Rev 2009, 33(2):138-158.
27. Wechsler H., Lee J.E., Kuo M., Lee H. College binge drinking in the 1990s: a continuing problem, Results of the Harvard School of Public Health 1999 College Alcohol Study. J Am Coll Health 2000, 48(5):199-210.
28. Wacholder S. Binomial regression in GLIM: estimating risk ratios and risk differences. Am J Epidemiol 1986, 123(1):174-184.
29. Winer R.L., Feng Q., Hughes J.P., O'Reilly S., Kiviat N.B., Koutsky L.A. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis 2008, 197(2):279-282.
30. Haber G., Malow R.M., Zimet G.D. The HPV vaccine mandate controversy. J Pediatr Adolesc Gynecol 2007, 20(6):325-331.
31. Jain N., Euler G.L., Shefer A., Lu P., Yankey D., Markowitz L. Human papillomavirus (HPV) awareness and vaccination initiation among women in the United States, National Immunization Survey-Adult 2007. Prev Med 2009, 48(5):426-431.
32. de Bekker-Grob E.W., Hofman R., Donkers B., van Ballegooijen M., Helmerhorst T.J., Raat H., et al. Girls' preferences for HPV vaccination: a discrete choice experiment. Vaccine 2010, 28(41):6692-6697.
33. Dasbach E.J., Elbasha E.H., Insinga R.P. Mathematical models for predicting the epidemiologic and economic impact of vaccination against human papillomavirus infection and disease. Epidemiol Rev 2006, 28:88-100.